Cargando…
Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen
The ability of monoclonal antibodies against the Thy-1.1 differentiation antigen to inhibit the growth of transplanted syngeneic AKR/J SL2 leukemic cells has been previously demonstrated. In the present study we further examined therapy with monoclonal antibody of the IgG2a isotype, which was the mo...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1983
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2186954/ https://www.ncbi.nlm.nih.gov/pubmed/6403649 |
Ejemplares similares
-
Patients receiving murine monoclonal antibody therapy for malignancy develop T cells that proliferate in vitro in response to these antibodies as antigens.
por: Kosmas, C., et al.
Publicado: (1991) -
Characterization of monoclonal antibodies recognizing neurotropic Friend murine leukemia virus
por: Ikeda, Tomio, et al.
Publicado: (1995) -
Generation of Monoclonal Antibodies against Highly Conserved Antigens
por: Zhou, Hongzhe, et al.
Publicado: (2009) -
Production and Characterization of a Murine Monoclonal Antibody Against Human Ferritin
por: Bayat, Ali Ahmad, et al.
Publicado: (2013) -
Immunochemical and Immunohistological Analyses of Tumor‐associated Antigens Defined by Murine Monoclonal Antibodies against Human Pancreatic Carcinoma Cells
por: Koyama, Shohei, et al.
Publicado: (1988)